In the latest trading session, 0.86 million Voyager Therapeutics Inc (NASDAQ:VYGR) shares changed hands as the company’s beta touched 0.92. With the company’s most recent per share price at $6.55 changed hands at -$1.11 or -14.43% at last look, the market valuation stands at $357.44M. VYGR’s current price is a discount, trading about -78.93% off its 52-week high of $11.72. The share price had its 52-week low at $5.71, which suggests the last value was 12.82% up since then. When we look at Voyager Therapeutics Inc’s average trading volume, we note the 10-day average is 0.55 million shares, with the 3-month average coming to 468.72K.
Analysts gave the Voyager Therapeutics Inc (VYGR) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.30. If we narrow down to specifics, the data shows that 0 out of 2 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 1 recommended VYGR as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight. Voyager Therapeutics Inc’s EPS for the current quarter is expected to be -0.45.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Voyager Therapeutics Inc (NASDAQ:VYGR) trade information
Instantly VYGR was in red as seen in intraday trades today. With action -4.31%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -22.33%, with the 5-day performance at -4.31% in the red. However, in the 30-day time frame, Voyager Therapeutics Inc (NASDAQ:VYGR) is 7.46% up. Looking at the short shares, we see there were 2.99 million shares sold at short interest cover period of 6.27 days.
The consensus price target for the stock as assigned by Wall Street analysts is 16, meaning bulls need an upside of 59.06% from its recent market value. According to analyst projections, VYGR’s forecast low is 8 with 18 as the target high. To hit the forecast high, the stock’s price needs a -174.81% plunge from its current level, while the stock would need to soar -22.14% for it to hit the projected low.
Voyager Therapeutics Inc (VYGR) estimates and forecasts
Data shows that the Voyager Therapeutics Inc share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -14.31% over the past 6 months, a -142.76% in annual growth rate that is considerably lower than the industry average of 17.20%. Year-over-year growth is forecast to reach -71.20% down from the last financial year.
Consensus estimates given by 9 financial analysts project the company’s revenue in the current quarter to hit an average of 11.89M. 9 analysts are of the opinion that Voyager Therapeutics Inc’s revenue for the current quarter will be 11.43M. The company’s revenue for the corresponding quarters a year ago was 4.61M and 90.06M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 157.70%. The estimates for the next quarter sales put growth at -87.30%.
The 2024 estimates are for Voyager Therapeutics Inc earnings to decrease by -144.19%.
VYGR Dividends
Voyager Therapeutics Inc is expected to release its next quarterly earnings report on 2024-Nov-04.
Voyager Therapeutics Inc (NASDAQ:VYGR)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 17.01% of Voyager Therapeutics Inc shares while 69.11% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 83.28%. There are 69.11% institutions holding the Voyager Therapeutics Inc stock share, with BLACKROCK INC. the top institutional holder. As of 2024-06-30, the company held 9.3013% of the shares, roughly 5.31 million VYGR shares worth $42.02 million.
ARMISTICE CAPITAL, LLC holds the second largest percentage of outstanding shares, with 9.1041% or 5.2 million shares worth $41.13 million as of 2024-06-30.
Among Mutual Funds, the top two as of Jun 30, 2024 were Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF. With 1.63 shares estimated at $10.69 million under it, the former controlled 2.99% of total outstanding shares. On the other hand, iShares Russell 2000 ETF held about 2.24% of the shares, roughly 1.22 shares worth around $8.01 million.
